북미의 핵산 분리 및 정제 시장 규모, 점유율, 동향 분석 : 제품별, 유형별, 방법별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

North America Nucleic Acid Isolation & Purification Market Growth & Trends:

The North America nucleic acid isolation and purification market size is expected to reach USD 4.15 billion by 2030, growing at a CAGR of 10.0% from 2025 to 2030. This growth is driven by the increasing demand for advanced molecular diagnostics, rising investments in genomics and personalized medicine, and expanding drug discovery and clinical research applications. Technological advancements in automation and high-throughput systems fuel market expansion, alongside the growing prevalence of genetic disorders and infectious diseases that require accurate nucleic acid analysis.

Moreover, growing awareness and adoption of precision agriculture and environmental genomics are emerging as important growth drivers for the nucleic acid isolation and purification market. In precision agriculture, nucleic acid technologies enable detailed genetic analysis of crops and soil microbiomes, improving yield, disease resistance, and sustainability. Similarly, environmental genomics applications involve monitoring biodiversity and detecting pathogens in ecosystems. These expanding uses create new demand for advanced nucleic acid isolation tools, broadening the market beyond traditional healthcare and research sectors. As industries recognize the value of genetic insights for optimizing resources and environmental management, market growth is further accelerated.

However, the high costs associated with advanced automated nucleic acid isolation systems and consumables pose a significant restraint, particularly for smaller laboratories and emerging markets. Additionally, the complexity of specific technologies and the need for specialized training can limit widespread adoption. Regulatory challenges and strict compliance requirements further slow market expansion. These factors collectively hinder accessibility and affordability, restricting growth despite rising demand for nucleic acid purification solutions.

North America Nucleic Acid Isolation And Purification Market Report Highlights:

• Based on product, the kits & reagents held the largest market share in 2024. This is attributed to their ease of use and broad application in research and diagnostics. Continuous innovation and cost-effectiveness further support their widespread adoption. The instruments segment is expected to grow fastest over the forecast period.
• The DNA isolation & purification segment dominated the type market share in 2024 and is anticipated to grow at the fastest CAGR over the forecast period. This is driven by increasing demand for DNA analysis in genomics research, clinical diagnostics, and biopharmaceutical development. However, RNA isolation & purification are anticipated to grow at a significant CAGR over the forecast period.
• The drug discovery & development as an application held the largest market share of 35.76% in 2024 and is anticipated to grow at the fastest CAGR over the forecast period. Rising R&D investments, increased use of nucleic acid analysis for target identification, and the growing demand for precision medicine and biomarker discovery drive this. However, Precision Medicine is anticipated to grow at a significant CAGR over the forecast period.
• The magnetic beads segment dominated the method segment with the largest share in 2024 and is anticipated to grow at the fastest CAGR over the forecast period. This growth is attributed to its high efficiency, scalability, and ability to deliver rapid, pure nucleic acid isolation, making it ideal for high-throughput and automated applications. However,column-based methods are expected to grow significantly over the forecast period.
• The hospitals and diagnostic centers segment dominated the end use segment with the largest share in 2024. This growth is attributed to the increasing adoption of nucleic acid-based diagnostic tests, the rising prevalence of infectious and genetic diseases, and the expanding clinical testing infrastructure across the region. However,pharmaceutical & biotechnology companies are expected to grow at the highest rate over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Type
  • 1.2.3. Application
  • 1.2.4. Method
  • 1.2.5. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. North America Nucleic Acid Isolation & Purification Market Variables & Trends

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing incidence of cancer, genetic disorders, and infectious diseases
    • 3.2.1.2. Increase in public-private funding for biotechnology and life science research
    • 3.2.1.3. Advancements in automation
    • 3.2.1.4. Growth in NGS technologies
    • 3.2.1.5. Growing demand for genetically modified crops and organisms
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Expensive instruments and consequent low penetration in emerging countries
    • 3.2.2.2. Challenges related to the use of big data and bioinformatics
• 3.3. North America Nucleic Acid Isolation & Purification Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. North America Nucleic Acid Isolation & Purification Market: Product Estimates & Trend Analysis

• 4.1. Product Segment Dashboard
• 4.2. North America Nucleic Acid Isolation & Purification Market Product Movement Analysis
• 4.3. North America Nucleic Acid Isolation & Purification Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Kits & Reagents
  • 4.4.1. Kits & Reagents Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 4.5. Instrument
  • 4.5.1. Instrument Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 4.5.2. Manual
    • 4.5.2.1. Manual Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 4.5.3. Automatic
    • 4.5.3.1. Automatic Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 5. North America Nucleic Acid Isolation & Purification Market: Type Estimates & Trend Analysis

• 5.1. Type Segment Dashboard
• 5.2. North America Nucleic Acid Isolation & Purification Market Type Movement Analysis
• 5.3. North America Nucleic Acid Isolation & Purification Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 5.4. DNA Isolation & Purification
  • 5.4.1. DNA Isolation & Purification Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 5.4.2. Genomic DNA Isolation & Purification
    • 5.4.2.1. Genomic DNA Isolation & Purification Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 5.4.3. Plasmid DNA Isolation & Purification
    • 5.4.3.1. Plasmid DNA Isolation & Purification Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 5.4.4. Viral DNA Isolation & Purification
    • 5.4.4.1. Viral DNA Isolation & Purification Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 5.4.5. Other
    • 5.4.5.1. Other Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 5.5. RNA Isolation & Purification
  • 5.5.1. RNA Isolation & Purification Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 5.5.2. miRNA Isolation & Purification
    • 5.5.2.1. miRNA Isolation & Purification Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 5.5.3. mRNA Isolation & Purification
    • 5.5.3.1. mRNA Isolation & Purification Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 5.5.4. Total RNA Isolation & Purification
    • 5.5.4.1. Total RNA Isolation & Purification Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 5.5.5. Other
    • 5.5.5.1. Other Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 6. North America Nucleic Acid Isolation & Purification Market: Application Estimates & Trend Analysis

• 6.1. Application Segment Dashboard
• 6.2. North America Nucleic Acid Isolation & Purification Market Application Movement Analysis
• 6.3. North America Nucleic Acid Isolation & Purification Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 6.4. Precision Medicine
  • 6.4.1. Precision Medicine Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 6.5. Diagnostics
  • 6.5.1. Diagnostics Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 6.6. Drug Discovery & Development
  • 6.6.1. Drug Discovery & Development Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 6.7. Agriculture and Animal Research
  • 6.7.1. Agriculture and Animal Research Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 6.8. Other Applications
  • 6.8.1. Other Applications Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 7. North America Nucleic Acid Isolation & Purification Market: Method Estimates & Trend Analysis

• 7.1. Method Segment Dashboard
• 7.2. North America Nucleic Acid Isolation & Purification Market Method Movement Analysis
• 7.3. North America Nucleic Acid Isolation & Purification Market Size & Trend Analysis, by Method, 2018 to 2030 (USD Million)
• 7.4. Column-based
  • 7.4.1. Column-based Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 7.5. Magnetic Beads
  • 7.5.1. Magnetic Beads Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 7.6. Reagent-based
  • 7.6.1. Reagent-based Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 7.7. Others
  • 7.7.1. Others Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 8. North America Nucleic Acid Isolation & Purification Market: End Use Estimates & Trend Analysis

• 8.1. End Use Segment Dashboard
• 8.2. North America Nucleic Acid Isolation & Purification Market End Use Movement Analysis
• 8.3. North America Nucleic Acid Isolation & Purification Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 8.4. Academic Research Institutes
  • 8.4.1. Academic Research Institutes Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 8.5. Pharmaceutical & Biotechnology Companies
  • 8.5.1. Pharmaceutical & Biotechnology Companies Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 8.6. Contract Research Organizations
  • 8.6.1. Contract Research Organizations Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 8.7. Hospitals and Diagnostic Centers
  • 8.7.1. Hospitals and Diagnostic Centers Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 8.8. Other End Use
  • 8.8.1. Other End Use Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 9. North America Nucleic Acid Isolation & Purification Market: Country Estimates & Trend Analysis

• 9.1. Country Market Share Analysis, 2024 & 2030
• 9.2. Country Market Dashboard
• 9.3. U.S.
  • 9.3.1. Key country dynamics
  • 9.3.2. Regulatory framework
  • 9.3.3. Competitive scenario
  • 9.3.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
• 9.4. Canada
  • 9.4.1. Key country dynamics
  • 9.4.2. Regulatory framework
  • 9.4.3. Competitive scenario
  • 9.4.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 9.5. Mexico
  • 9.5.1. Key country dynamics
  • 9.5.2. Regulatory framework
  • 9.5.3. Competitive scenario
  • 9.5.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Participant Categorization
• 10.2. Company Market Position Analysis, 2024
• 10.3. Strategy Mapping
• 10.4. Participants Overview
  • 10.4.1. Thermo Fisher Scientific, Inc.
    • 10.4.1.1. Company overview
    • 10.4.1.2. Financial performance
    • 10.4.1.3. Product benchmarking
    • 10.4.1.4. Strategic initiatives
  • 10.4.2. QIAGEN
    • 10.4.2.1. Company overview
    • 10.4.2.2. Financial performance
    • 10.4.2.3. Product benchmarking
    • 10.4.2.4. Strategic initiatives
  • 10.4.3. Merck KGaA
    • 10.4.3.1. Company overview
    • 10.4.3.2. Financial performance
    • 10.4.3.3. Product benchmarking
    • 10.4.3.4. Strategic initiatives
  • 10.4.4. Illumina, Inc.
    • 10.4.4.1. Company overview
    • 10.4.4.2. Financial performance
    • 10.4.4.3. Product benchmarking
    • 10.4.4.4. Strategic initiatives
  • 10.4.5. Danaher
    • 10.4.5.1. Company overview
    • 10.4.5.2. Financial performance
    • 10.4.5.3. Product benchmarking
    • 10.4.5.4. Strategic initiatives
  • 10.4.6. F. Hoffmann-La Roche Ltd.
    • 10.4.6.1. Company overview
    • 10.4.6.2. Financial performance
    • 10.4.6.3. Product benchmarking
    • 10.4.6.4. Strategic initiatives
  • 10.4.7. Agilent Technologies
    • 10.4.7.1. Company overview
    • 10.4.7.2. Financial performance
    • 10.4.7.3. Product benchmarking
    • 10.4.7.4. Strategic initiatives
  • 10.4.8. Bio-Rad Laboratories, Inc
    • 10.4.8.1. Company overview
    • 10.4.8.2. Financial performance
    • 10.4.8.3. Product benchmarking
    • 10.4.8.4. Strategic initiatives
  • 10.4.9. Takara Bio Inc.
    • 10.4.9.1. Company overview
    • 10.4.9.2. Financial performance
    • 10.4.9.3. Product benchmarking
    • 10.4.9.4. Strategic initiatives
  • 10.4.10. Promega Corporation
    • 10.4.10.1. Company overview
    • 10.4.10.2. Financial performance
    • 10.4.10.3. Product benchmarking
    • 10.4.10.4. Strategic initiatives